The Latest Breaking News from Catalyst

For most of us, dancing is a fun way to unwind, or something we do after a few too many drinks on a Saturday night. But what if dancing can actually help to slow — or in some cases even reverse — the ageing process?

A niche piece of technology used by scientists and researchers to rapidly work out the dangers and effects of natural hazard events is winning acclaim and international interest

Employability course created by company related to job agency labelled a ‘waste of time, waste of resources’ by one jobseeker

Here's a roundup of top developments in the biotech space over the last 24 hours:

Catholic educators are moving towards explicit, direct instruction over inquiry-based learning - and the early results are very promising.

The centre is part of the Newcastle Helix development, which aims to bring together firms in a number of leading edge scientific sectors

Agricultural businesses need not worry about their initial emissions result being held against them, according to industry leaders

The teams will now go on to Co-Founders+ where they'll be given mentors and specialists to accelerate their ideas

The winner of the influential competition will take home £25,000

Nearly 20 years ago, Aotearoa – and Catalyst – were at the forefront of an e-learning revolution. Now, with the creation of Te Pūkenga, there's a chance to do it again, writes Don Christie

Catalyst Biosciences Inc (NASDAQ:CBIO) has agreed to sell its portfolio of protease medicines that regulate complement to Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) for $60 million. "This sale is part of the ongoing strategic process that we announced in February to explore alternatives and create value for shareholders. We have significantly reduced our cash burn and continue…